Showing results (141-150 of 170) with videos related to

Sort By:
Pageof 17
Life (Basel, Switzerland)|January 26, 2024
Survival Trends in Pediatric Differentiated Thyroid Cancer: A Middle Eastern PerspectiveAkram Al-Ibraheem, Mohamed Al-Shammaa, Ahmed Saad Abdlkadir, et al.
JCO Global Oncology|October 3, 2025
Metastasis-Directed Stereotactic Body Radiation Therapy in Oligometastatic and Oligoprogressive Solid Malignancy: Outcomes and Effect on Systemic TreatmentAbdulla Alzibdeh, Lina Wahbeh, Shatha Abu Taha, et al.
Oncology Reviews|January 22, 2026
Universal vs. ASCO guidelines-based germline genetic testing for newly diagnosed breast cancer patients in resource-restricted settingsHikmat Abdel-Razeq, Faris Tamimi, Sarah Abdel-Razeq, et al.
Frontiers in Oncology|March 18, 2026
Prostatectomy versus definitive radiation for localized prostate cancer: revisiting the debate at a tertiary cancer centerRamiz Abu-Hijlih, Abdulla Alzibdeh, Haneen Abaza, et al.
Journal of Thrombosis and Thrombolysis|July 10, 2023
COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM studyHikmat Abdel-Razeq, Baha' Sharaf, Mohammed J Al-Jaghbeer, et al.
The Lancet. Oncology|June 14, 2025
Transforming cancer care in Jordan: a 10-year comprehensive patient-centred strategy guided by local expertsHikmat Abdel-Razeq, Yaser Rayyan, Kamal Al-Rabi, et al.
Journal of Pain and Symptom Management|February 26, 2019
Intensity of Cancer Care Near the End of Life at a Tertiary Care Cancer Center in JordanHikmat Abdel-Razeq, Omar Shamieh, Mahmoud Abu-Nasser, et al.
Molecular Genetics & Genomic Medicine|December 20, 2022
Prevalence and clinical implications of germline mutations among Jordanian patients with ovarian cancer. The Jordanian exploratory cancer genetics (Jo-ECAG) ovarian studyHikmat Abdel-Razeq, Khansa Al-Azzam, Shatha Elemian, et al.
Hematology (Amsterdam, Netherlands)|April 1, 2026
Survival and prognostic features of early-stage diffuse large B-cell lymphoma in older adultsMohammad Ma'koseh, Omar Shahin, Alaa Abufara, et al.
Journal of Translational Medicine|July 7, 2026
Minimally invasive circulating MicroRNA signatures for breast cancer detection and neoadjuvant therapy response prediction in a multicenter MENA cohortRadhakrishnan Vishnubalaji, Hikmat Abdel-Razeq, Salahddin A Gehani, et al.
Pageof 17